The OR52A5 antibody is a rabbit-derived polyclonal antibody targeting the olfactory receptor family 52, subfamily A, member 5 (OR52A5). This receptor is part of the G-protein-coupled receptor (GPCR) superfamily and is implicated in odorant detection . The antibody is widely used in molecular biology for detecting OR52A5 in techniques such as Western blotting and ELISA .
Comprises two heavy and two light chains with variable (antigen-binding) and constant regions .
The C-terminal epitope (sequence: FQLPQKEARFKAC) ensures specificity for OR52A5 .
Polyclonal nature allows recognition of multiple epitopes, enhancing detection sensitivity .
Studies on antibody genetics (e.g., conserved VH gene responses to pathogens ) inform the design of antibodies like OR52A5, which target evolutionarily stable regions.
OR52A5’s role in olfaction may link to sensory research or disease models involving chemoreceptor dysfunction.
Specificity: Cross-reactivity with similar olfactory receptors requires further validation.
Functional Studies: OR52A5’s ligand specificity and downstream signaling mechanisms remain understudied.
OR52A5 (Olfactory Receptor Family 52 Subfamily A Member 5) is a G-protein-coupled receptor involved in olfaction. It belongs to a family of olfactory receptors that interact with odorant molecules to initiate neuronal responses for smell perception . OR52A5 and other members of the OR52 family are known to recognize carboxylic acids as odorants .
Antibodies against OR52A5 are crucial because they:
Enable visualization and quantification of receptor expression in olfactory tissues
Allow investigation of receptor trafficking and localization
Support studies on olfactory signal transduction pathways
Help correlate receptor expression with functional olfactory responses
OR52A5 antibodies can be utilized in multiple experimental approaches:
Western blot analysis has been successfully performed using Jurkat cell lysates, confirming specific detection of OR52A5 .
Proper validation requires several controls:
Positive controls: Jurkat cells have been documented to express OR52A5 and serve as appropriate positive controls
Negative controls: Include samples known not to express OR52A5
Blocking peptide controls: The specificity can be verified by pre-incubating the antibody with the synthesized peptide, which should eliminate signal in Western blot as demonstrated in existing validation studies
Isotype controls: Include appropriate rabbit IgG isotype controls to assess non-specific binding
The structural analysis of the OR52 family reveals critical considerations for antibody development:
The OR52 family exhibits unique structural elements including:
A large opening between transmembrane helices (TMs) 5 and 6 in the apo state
Inward movement (7.4 Å) of the extracellular segment of TM6 upon odorant binding
Conserved aromatic interaction networks involving F14, F96, and F170
Most commercially available OR52A5 antibodies target:
Researchers should select antibodies targeting epitopes that:
Are accessible in native protein conformation
Avoid the odorant binding pocket that may be occupied during functional studies
Are unique to OR52A5 to prevent cross-reactivity with related receptors
Cross-reactivity is a significant concern when studying olfactory receptors due to their sequence similarities:
OR52A5 and OR52A4 share high sequence homology, particularly within transmembrane domains
Cross-reactivity risk factors include:
Targeting highly conserved regions across the OR52 family
Using polyclonal antibodies that recognize multiple epitopes
Insufficient validation against related receptors
To minimize cross-reactivity:
Select antibodies targeting unique regions, preferably in the variable N-terminal or C-terminal domains
Validate against recombinant OR52A4 protein
Include appropriate blocking experiments with specific peptides
Consider using knockout/knockdown models as negative controls
Structural studies reveal that the OR52 family, including OR52A5, recognizes carboxylic acids through specific molecular interactions:
R265 in position 6.59 forms critical interactions with the carboxyl group of odorants like octanoate, maintaining an average distance of 2.8 Å in molecular dynamics simulations
This arginine residue is highly conserved in OR51/52 families but not in other OR families
Mutation of R265 to alanine completely abolishes downstream signaling
OR52A5 antibodies can be employed to:
Immunoprecipitate receptor-ligand complexes for structural analysis
Study conformational changes upon odorant binding through conformation-specific antibodies
Investigate co-localization with signaling partners like G proteins
Assess receptor internalization following odorant stimulation
Based on published validation studies, the following protocol is recommended:
Sample Preparation:
Prepare cell lysates from Jurkat cells or tissues expressing OR52A5
Use RIPA buffer supplemented with protease inhibitors
Denature samples at 95°C for 5 minutes in reducing sample buffer
Electrophoresis and Transfer:
Load 20-50 μg protein per lane
Use 10-12% SDS-PAGE gels
Transfer to PVDF membrane at 100V for 1 hour or 30V overnight
Immunoblotting:
Block membrane with 5% non-fat milk in TBST for 1 hour
Incubate with OR52A5 antibody at 1:500-1:2000 dilution overnight at 4°C
Wash 3x with TBST, 5 minutes each
Incubate with HRP-conjugated anti-rabbit secondary antibody (1:5000) for 1 hour
Wash 3x with TBST, 5 minutes each
Develop using ECL substrate
Expected Results:
OR52A5 appears at approximately 36 kDa (calculated molecular weight: 35.955 kDa)
Some antibodies may detect a band at ~72 kDa, which could represent dimerized receptor
Tissue Preparation:
Fix olfactory tissue in 4% paraformaldehyde for 24 hours
Cryoprotect in 30% sucrose before sectioning
Section at 10-20 μm thickness
Staining Protocol:
Perform antigen retrieval using citrate buffer (pH 6.0) at 95°C for 20 minutes
Block with 10% normal serum + 0.3% Triton X-100 for 1 hour
Incubate with OR52A5 antibody at 1:200-1:1000 dilution overnight at 4°C
Wash 3x with PBS, 5 minutes each
Incubate with fluorophore-conjugated secondary antibody for 1 hour
Counterstain with DAPI for nuclear visualization
Mount with anti-fade medium
Optimization Strategies:
Titrate antibody concentration to determine optimal signal-to-noise ratio
Include positive control tissues with known OR52A5 expression
Perform dual immunofluorescence with neuronal markers to confirm expression in olfactory neurons
Consider tyramide signal amplification for low-abundance receptors
Based on manufacturer recommendations:
Storage Conditions:
Handling Guidelines:
Aliquot antibodies upon receipt to minimize freeze-thaw cycles
Store in glycerol-containing buffers (typically 50% glycerol)
Most preparations contain sodium azide (0.02-0.09%) as preservative
Stability Indicators:
Signs of reduced activity include increased background, diminished specific signal, and requirement for higher concentrations
False Positives:
Cross-reactivity with related olfactory receptors (particularly other OR52 family members)
Non-specific binding to hydrophobic domains common in membrane proteins
Secondary antibody cross-reactivity
Endogenous peroxidase or alkaline phosphatase activity
False Negatives:
Epitope masking due to protein-protein interactions
Conformation-dependent epitopes lost during sample processing
Low expression levels below detection threshold
Protein degradation during sample preparation
Troubleshooting Approaches:
For false positives:
Perform peptide competition assays
Increase washing stringency
Optimize blocking conditions
Use more specific detection methods
For false negatives:
Try alternative extraction methods to preserve epitopes
Use signal enhancement methods
Target different epitopes with alternative antibodies
Enrich target protein through immunoprecipitation
Validation Strategies:
Peptide blocking experiments: Pre-incubate antibody with immunizing peptide to block specific binding
Molecular weight verification: OR52A5 should appear at approximately 36 kDa
Cell line validation: Test antibody in cells with known OR52A5 expression (e.g., Jurkat cells)
siRNA knockdown: Demonstrate signal reduction following OR52A5 knockdown
Cross-validation: Confirm results using multiple antibodies targeting different epitopes
Mass spectrometry: Confirm identity of immunoprecipitated proteins
Published Validation Data:
Western blot analysis has demonstrated specific detection in Jurkat cells, with signal elimination when blocked with synthesized peptide , confirming antibody specificity.
Integrated Experimental Approaches:
ChIP-seq analysis using OR52A5 antibodies:
Identify transcription factors regulating OR52A5 expression
Map enhancer elements controlling receptor expression patterns
Compare chromatin landscape in different olfactory cell populations
Single-cell multi-omics:
Combine OR52A5 immunostaining with single-cell RNA-seq
Correlate receptor protein levels with transcriptional profiles
Identify co-expressed signaling components
Proximity labeling:
Fuse promiscuous biotin ligases to OR52A5
Use OR52A5 antibodies to verify expression
Identify proteins in proximity to OR52A5 during odorant stimulation
Functional correlation studies:
Combine calcium imaging with post-hoc immunostaining
Correlate OR52A5 expression levels with response magnitude to carboxylic acids
Use antibodies to quantify receptor density at the membrane
Experimental Design for Trafficking Studies:
Surface biotinylation:
Biotinylate surface proteins before odorant stimulation
Use OR52A5 antibodies to immunoprecipitate receptors
Quantify changes in biotinylated fraction after stimulation
Pulse-chase immunostaining:
Label surface OR52A5 with antibodies at 4°C
Stimulate with odorants at 37°C
Track receptor internalization using confocal microscopy
Co-localization studies:
Use OR52A5 antibodies with markers for:
Early endosomes (EEA1)
Recycling endosomes (Rab11)
Lysosomes (LAMP1)
Quantify co-localization coefficients following odorant exposure
Live-cell imaging:
Use fluorescently labeled Fab fragments of OR52A5 antibodies
Perform time-lapse imaging during odorant stimulation
Quantify membrane vs. intracellular distribution over time